NEW DELHI, India: The Merck drug, Molnupiravir, an antiviral pill that treats mild-to-moderate COVID-19 cases, could be given emergency authorization use "within days" in India, according to Dr. Ram Vishwakarma, Chairman of the Covid Strategy Group, as quoted by New Delhi TV.
He added that the drug is for use by adults who are at risk of severe COVID-19 or hospitalization.
Another Covid pill developed by Pfizer, named Paxlovid, may take more time to be approved.
